Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
2004, 287 (6): E1209-E1215
Keeping an eye on things can help spot any problems
Clinical superiority must be assessed through direct trials examining weight change, metabolic outcomes, adverse events, discontinuation rates and longer-term safety
Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3- methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl] thiazolidine): A highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
Following the restructuring and exit of structured debt holders, interest costs are expected to decline by around Rs 300 crore year-on-year in FY27, while capex is also set to moderate as most major expansions have been completed, said Aman Goyal, Research Associate at Axis Securities
US$ 24.81
US$ 24.23
US$ 22.61
US$ 25.16
US$ 21.87
